Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
10/28/2022* -- Results Q3 2022 -- 4.66 --
10/28/2022* 09:00 EST Earnings Call Q3 2022 -- -- --
07/28/2022 09:00 EST Earnings Call Q2 2022 -- -- --
07/28/2022 -- Results Q2 2022 4.96 4.68 5.90%
04/28/2022 -- Results Q1 2022 6.11 6.00 1.81%
04/28/2022 09:00 EST Earnings Call Q1 2022 -- -- --
02/10/2022 -- Results Q4 2021 6.77 6.00 12.87%
02/10/2022 09:00 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 10/28/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 07/28/2022
Beat/Miss Upgrade
Return Since -15.90%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market.
URL https://www.labcorp.com
Investor Relations URL https://ir.labcorp.com
HQ State/Province North Carolina
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Value
Next Earnings Release Oct. 28, 2022 (est.)
Last Earnings Release Jul. 28, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Aug. 17, 2022

Dividends

Dividend Per Share (TTM) 0.72
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.4992
Yield to Sector 0.3841
Yield to Industry 1.840
Last Dividend Amt. 0.72
Dividend Frequency Quarterly
Last Ex-Dividend Date Aug. 17, 2022
Yield (TTM) 0.68%
Forward Yield 1.36%
Payout Ratio 3.35%
Cash Payout Ratio 3.58%
Consistent Payer (5Y) No
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
14.59%
3.83%
24.25%
-20.78%
33.88%
20.32%
54.36%
-32.25%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-21.61%
8.35%
31.89%
9.16%
-13.84%
31.15%
14.04%
47.86%
-28.26%
--
--
--
--
--
54.43%
18.78%
-27.92%
-58.68%
-88.50%
-99.97%
-99.39%
-89.16%
-15.67%
-56.75%
-57.81%
-44.02%
-2.15%
19.27%
24.31%
-52.35%
107.0%
-47.43%
-66.83%
As of September 23, 2022.

Profile

Edit
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market.
URL https://www.labcorp.com
Investor Relations URL https://ir.labcorp.com
HQ State/Province North Carolina
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Value
Next Earnings Release Oct. 28, 2022 (est.)
Last Earnings Release Jul. 28, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Aug. 17, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
IHF 57.01M USD 3.65%
CAAIX 39.04M USD 3.55%
JMIVX 59.08M USD 2.87%
ARGFX 69.57M USD 2.71%
MRBVX 47.93M USD 2.28%
CII 16.69M USD 2.06%
BDJ 34.05M USD 2.02%
FXH 28.04M USD 1.98%
JMVQX 287.88M USD 1.94%
JMEEX 34.83M USD 1.15%
FTA 8.886M USD 0.84%
JHMM 9.021M USD 0.38%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter LH Tweets